-
My Account
In App
My Account
BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Dec 03, 09:52Prev. Close
88.10
Open Price
83.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
86.85 (1200)
| Key Financial Ratios of Accretion Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 8.48 | 9.69 | 0.27 | 0.26 | |
| Diluted EPS (Rs.) | 8.48 | 9.69 | 0.27 | 0.26 | |
| Cash EPS (Rs.) | 9.26 | 11.81 | 2.67 | 2.89 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 18.71 | 13.37 | 10.00 | 10.00 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 18.71 | 13.37 | 10.00 | 10.00 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 70.23 | 84.16 | 76.47 | 72.46 | |
| PBDIT/Share (Rs.) | 14.66 | 19.41 | 5.57 | 6.28 | |
| PBIT/Share (Rs.) | 13.71 | 17.29 | 3.16 | 3.64 | |
| PBT/Share (Rs.) | 11.95 | 14.40 | 0.36 | 0.34 | |
| Net Profit/Share (Rs.) | 8.32 | 9.69 | 0.27 | 0.26 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 20.87 | 23.05 | 7.27 | 8.66 | |
| PBIT Margin (%) | 19.52 | 20.54 | 4.13 | 5.02 | |
| PBT Margin (%) | 17.01 | 17.11 | 0.47 | 0.46 | |
| Net Profit Margin (%) | 11.84 | 11.51 | 0.35 | 0.35 | |
| Return on Networth / Equity (%) | 44.44 | 72.46 | 2.70 | 2.56 | |
| Return on Capital Employed (%) | 67.27 | 55.84 | 17.99 | 18.64 | |
| Return on Assets (%) | 17.03 | 14.32 | 0.50 | 0.44 | |
| Total Debt/Equity (X) | 0.92 | 2.52 | 2.20 | 2.47 | |
| Asset Turnover Ratio (%) | 1.71 | 1.41 | 1.53 | 0.00 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 1.44 | 1.47 | 1.05 | 1.01 | |
| Quick Ratio (X) | 0.56 | 0.48 | 0.49 | 0.42 | |
| Inventory Turnover Ratio (X) | 2.49 | 3.03 | 4.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 |
